Future of Dengue Market EpiCast Report & Epidemiology Forecast to 2023 - PowerPoint PPT Presentation

About This Presentation
Title:

Future of Dengue Market EpiCast Report & Epidemiology Forecast to 2023

Description:

Get a detailed report at . Researcher epidemiologists forecast that laboratory-confirmed dengue cases in the 5MM will increase from an annual average of 304,608 cases from 2009-2013 to 339,104 cases in 2023 with an annual growth rate (AGR) of 1.13%. Brazil will have almost half the number of reported laboratory-confirmed dengue cases among the 5MM throughout the forecast period (207,000 cases in 2023). Researcher epidemiologists believe that introductions of new or long-dormant dengue serotypes would be a significant driver in disease transmission in the 5MM during the next 10 years. – PowerPoint PPT presentation

Number of Views:40
Slides: 7
Provided by: robertmcmillian
Category:

less

Transcript and Presenter's Notes

Title: Future of Dengue Market EpiCast Report & Epidemiology Forecast to 2023


1
EpiCast Report Dengue Epidemiology Forecast to
2023
Order this report by calling 1 888 391 5441 or
Send an email to sales_at_marketoptimizer.org with
your contact details and questions if any.
  • Published Mar 2014
  • Single User PDF US 3495
  • Corporate User PDF US 10485

2
EpiCast Report Dengue Epidemiology Forecast to
2023
  • Dengue fever is a febrile illness caused by a
    single-stranded flavirius most commonly
    transmitted by the Aedes aegypti mosquito. Dengue
    fever is one of the most prevalent
    arthropod-borne diseases affecting humans. The
    severity of dengue fever ranges from asymptomatic
    cases, to classic dengue fever, and to DHF or
    DSS.
  • Researcher epidemiologists sourced
    government-based publications for the forecast of
    reported laboratory-confirmed dengue fever cases,
    including official national dengue reports,
    weekly surveillance reports, and reportable
    disease databases.
  • Researcher epidemiologists forecast that
    laboratory-confirmed dengue cases in the 5MM will
    increase from an annual average of 304,608 cases
    from 2009-2013 to 339,104 cases in 2023 with an
    annual growth rate (AGR) of 1.13.

Call Now 1 888 391 5441 Email at
sales_at_marketoptimizer.org
3
EpiCast Report Dengue Epidemiology Forecast to
2023
  • Brazil will have almost half the number of
    reported laboratory-confirmed dengue cases among
    the 5MM throughout the forecast period (207,000
    cases in 2023). Researcher epidemiologists
    believe that introductions of new or long-dormant
    dengue serotypes would be a significant driver in
    disease transmission in the 5MM during the next
    10 years.
  • This report is based on laboratory-confirmed
    dengue cases reported by the national
    surveillance systems of the 5MM. Therefore, it
    should be used with the understanding that
    reported cases are a function of the dengue case
    burden in the country as well as the type and
    capacity of the dengue surveillance system.
  • This report provide a comprehensive analysis of
    dengue fever epidemiology in the 5MM,
    incorporating risk factors, disease burden,
    outbreak periodicity, serotype circulation
    pattern, regional variations in disease pattern,
    and ageand sex-specific distribution. The
    analysis is based on strong sources, including
    official national dengue reports, weekly
    surveillance reports, and reportable disease
    databases.

Call Now 1 888 391 5441 Email at
sales_at_marketoptimizer.org
4
EpiCast Report Dengue Epidemiology Forecast to
2023
  • Scope
  • The Dengue EpiCast Report provides an overview of
    the dengue fever risk factors and comorbidities,
    global and historical epidemiology trends, and
    circulating serotypes (DENV-1, DENV-2, DENV-3,
    and DENV-4) in five major markets (5MM) (Brazil,
    India, Mexico, Singapore, and Thailand). In
    addition, this report includes a 10-year
    epidemiology forecast for the reported
    laboratory-confirmed incident cases of dengue
    fever (including classic dengue fever, dengue
    hemorrhagic fever (DHF), and dengue shock
    syndrome (DSS)) for the 5MM. The reported
    laboratory-confirmed incident cases are segmented
    by sex and age (The dengue epidemiology report is
    written and developed by Mastersand PhD-level
    epidemiologists.
  • The EpiCast Report is in-depth, high quality,
    transparent and market-driven, providing expert
    analysis of disease trends in the 5MM.
  • Inquire about this report at http//www.marketopti
    mizer.org/contacts/purchase?rname7298

Call Now 1 888 391 5441 Email at
sales_at_marketoptimizer.org
5
EpiCast Report Dengue Epidemiology Forecast to
2023
  • Reasons to buy
  • Develop business strategies by understanding the
    trends shaping and driving the global dengue
    market.
  • Quantify patient populations in the global dengue
    market to improve product design, pricing, and
    launch plans.
  • Organize sales and marketing efforts by
    identifying the sex and age groups that present
    the best opportunities for dengue pharmaceutical
    products in each of the markets covered.
  • Get a detailed report at http//www.marketoptimize
    r.org/epicast-report-dengue-epidemiology-forecast-
    to-2023.html .

Call Now 1 888 391 5441 Email at
sales_at_marketoptimizer.org
6
EpiCast Report Dengue Epidemiology Forecast to
2023
  • About Us
  • marketoptimizer.org is an online market research
    reports library of 250,000 in-depth studies of
    over 5000 micro markets. Our database includes
    reports by leading publishers from across the
    globe. We provide 24/7 online and offline support
    service to our customers. marketoptimizer.org
    also offers company data, country profiles,
    trends, information and analysis on the sector of
    your interest.
  • Visit Us _at_
  • http//www.marketoptimizer.org
  • Follow Us

Call Now 1 888 391 5441 Email sales _at_
sales_at_marketoptimizer.org
Write a Comment
User Comments (0)
About PowerShow.com